Considerations in developing medical countermeasures against chemical ocular toxicity.
Toxicol Lett
; 334: 1-3, 2020 Nov 01.
Article
em En
| MEDLINE
| ID: mdl-32916183
ABSTRACT
The Chemical Countermeasures Research Program (CCRP) was established in 2006 by the National Institute of Allergy and Infectious Diseases (NIAID/NIH) on behalf of the National Institutes of Health Office of the Director (NIH OD). It is a trans-NIH initiative to expedite the discovery and early development of medical countermeasures (MCMs) that can reduce mortality and serious morbidity during and after large consequence public health emergency involving the deliberate or accidental large-scale release of highly toxic chemicals (HTCs).
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Substâncias Perigosas
/
Planejamento em Desastres
/
Olho
/
Contramedidas Médicas
/
Neuropatia Óptica Tóxica
Tipo de estudo:
Risk_factors_studies
Limite:
Humans
País/Região como assunto:
America do norte
Idioma:
En
Revista:
Toxicol Lett
Ano de publicação:
2020
Tipo de documento:
Article